Patents Assigned to Hope Medical Enterprises, Inc.
  • INTRADIALYTIC USE OF SODIUM THIOSULFATE
    Publication number: 20240100086
    Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
    Type: Application
    Filed: August 29, 2023
    Publication date: March 28, 2024
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventor: Craig Sherman
  • SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20240101422
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Application
    Filed: July 25, 2023
    Publication date: March 28, 2024
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Intradialytic use of sodium thiosulfate
    Patent number: 11779596
    Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
    Type: Grant
    Filed: August 9, 2021
    Date of Patent: October 10, 2023
    Assignee: HOPE MEDICAL ENTERPRISES, INC.
    Inventor: Craig Sherman
  • Sodium thiosulfate-containing pharmaceutical compositions
    Patent number: 11753300
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: September 12, 2023
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium thiosulfate-containing pharmaceutical compositions
    Patent number: 11753301
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Grant
    Filed: February 13, 2023
    Date of Patent: September 12, 2023
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • INTRADIALYTIC USE OF SODIUM NITRITE
    Publication number: 20230256005
    Abstract: Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.
    Type: Application
    Filed: January 3, 2023
    Publication date: August 17, 2023
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventor: Craig Sherman
  • SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20230183067
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Application
    Filed: February 13, 2023
    Publication date: June 15, 2023
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium nitrite-containing pharmaceutical compositions
    Patent number: 11583550
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: February 21, 2023
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Intradialytic use of sodium nitrite
    Patent number: 11564938
    Abstract: Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.
    Type: Grant
    Filed: November 23, 2020
    Date of Patent: January 31, 2023
    Assignee: Hope Medical Enterprises, Inc.
    Inventor: Craig Sherman
  • SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220063999
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Application
    Filed: September 8, 2021
    Publication date: March 3, 2022
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • INTRADIALYTIC USE OF SODIUM THIOSULFATE
    Publication number: 20220031735
    Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
    Type: Application
    Filed: August 9, 2021
    Publication date: February 3, 2022
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventor: Craig Sherman
  • Sodium thiosulfate-containing pharmaceutical compositions
    Patent number: 11142456
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: October 12, 2021
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Intradialytic use of sodium thiosulfate
    Patent number: 11116790
    Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
    Type: Grant
    Filed: July 13, 2020
    Date of Patent: September 14, 2021
    Assignee: Hope Medical Enterprises, Inc.
    Inventor: Craig Sherman
  • INTRADIALYTIC USE OF SODIUM NITRITE
    Publication number: 20210077524
    Abstract: Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.
    Type: Application
    Filed: November 23, 2020
    Publication date: March 18, 2021
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventor: Craig Sherman
  • Intradialytic use of sodium nitrite
    Patent number: 10898512
    Abstract: Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: January 26, 2021
    Assignee: Hope Medical Enterprises, Inc.
    Inventor: Craig Sherman
  • Sodium nitrite-containing pharmaceutical compositions
    Patent number: 10898513
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Grant
    Filed: April 8, 2020
    Date of Patent: January 26, 2021
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • Sodium nitrite-containing pharmaceutical compositions
    Patent number: 10874691
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: December 29, 2020
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • INTRADIALYTIC USE OF SODIUM THIOSULFATE
    Publication number: 20200338120
    Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
    Type: Application
    Filed: July 13, 2020
    Publication date: October 29, 2020
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventor: Craig Sherman
  • Intradialytic use of sodium thiosulfate
    Patent number: 10744156
    Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: August 18, 2020
    Assignee: Hope Medical Enterprises, Inc.
    Inventor: Craig Sherman
  • Sodium thiosulfate-containing pharmaceutical compositions
    Patent number: 10723623
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: July 28, 2020
    Assignee: Hope Medical Enterprises, Inc.
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze